Meningioma

Neurobiology of Disease

Volumn , Issue , 2007, Pages 381-393

  Lamszus, Katrin ^a   Hagel, Christian ^a   Westphal, Manfred ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73249142226     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088592-3/50037-2     Document Type: Chapter

References (21)

1. Kepes J.J. Meningiomas 1982, Masson Publishing, France.
2. Lantos P.L., VandenBerg S.R., Kleihues P. Tumours of the nervous system. Greenfield's Neuropathology 1997, vol. 2:583-879. Arnold, New York. D.I. Graham, P.L. Lantos (Eds.).
3. Louis D.N., Scheithauer B.W., Budka H., von Deimling A., Kepes J.J. Meningiomas. Pathology and Genetics of Tumours of the Nervous System 2000, 176-184. IARC Press, Lyon, London. P. Kleihues, W.K. Cavenee (Eds.).
4. Kleihues P., Louis D.N., Scheithauer B.W., Rorke L.B., Reifenberger G., Burger P.C., Cavenee W.K. The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:215-225.
5. Lusis E., Gutmann D.H. Meningioma: an update. Curr. Opin. Neurol. 2004, 17:687-692.
6. Perry A., Scheithauer B.W., Stafford S.L., Lohse C.M., Wollan P.C. "Malignancy" in meningiomas: a clinicopatho-logic study of 116 patients, with grading implications. Cancer 1999, 85:2046-2056.
7. Drummond K.J., Zhu J.J., Black P.M. Meningiomas: updating basic science, management, and outcome. Neurologist 2004, 10:113-130.
8. Whittle I.R., Smith C., Navoo P., Collie D. Menin-giomas. Lancet 2004, 363:1535-1543.
9. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J. Neurochem. 1957, 20:22-39.
10. Collins V.P., Nordenskjold M., Dumanski J.P. The molecular genetics of meningiomas. Brain Pathol. 1990, 1:19-24.
11. Zang K.D. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cyto-genet. Cell Genet. 2001, 93:207-220.
12. Perry A., Gutmann D.H., Reifenberger G. Molecular pathogenesis of meningiomas. J. Neurooncol. 2004, 70:183-202.
13. Lamszus K. Meningioma pathology, genetics, and biology. J. Neuropathol. Exp. Neurol. 2004, 63:275-286.
14. Lamszus K., Vahldiek F., Mautner V.F., Schichor C., Tonn J., Stavrou D., Fillbrandt R., Westphal M., Kluwe L. Allelic losses in neurofibromatosis 2-associated meningiomas. J. Neuropathol. Exp. Neurol. 2000, 59:504-512.
15. Perry A., Dehner L.P. Meningeal tumors of child-hood and infancy. An update and literature review. Brain Pathol. 2003, 13:386-408.
16. Lamszus K., Lengler U., Schmidt N.O., Stavrou D., Ergun S., Westphal M. Vascular endothelial growth factor, hepa-tocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas. Neurosurgery 2000, 46:938-947.
17. Black P., Carroll R., Zhang J. The molecular biology of hormone and growth factor receptors in meningiomas. Acta. Neurochir. Suppl. 1996, 65:50-53.
18. Sanson M., Cornu P. Biology of meningiomas. Acta. Neurochir. (Wien.) 2000, 142:493-505.
19. McCutcheon I.E. The biology of meningiomas. J. Neurooncol. 1996, 29:207-216.
20. Sievers J., Pehlemann F.W., Baumgarten H.G., Berry M. Selective destruction of meningeal cells by 6-hydroxydopamine: a tool to study meningeal-neuroepithelial inter-action in brain development. Dev. Biol. 1985, 110:127-135.
21. Kalamarides M., Niwa-Kawakita M., Leblois H., Abramowski V., Perricaudet M., Janin A., Thomas G., Gutmann D.H., Giovannini M. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev. 2002, 16:1060-1065.